CNKI中非小细胞肺癌治疗进展高被引文献的计量分析

Bibliometric Analysis of Highly Cited Literatures on the Treatment Progress of Non-Small Cell Lung Cancer in the CNKI Database

目的:分析我国非小细胞肺癌治疗进展高被引文献的计量特征。方法:检索中国学术期刊全文数据库(CNKI) 2014~2020年的非小细胞肺癌治疗进展文献,参照普赖斯定律确定高被引文献,用Excel 2016统计分析被引频次、发表年份、期刊名称、文献作者、作者机构、关键词、基金类别。结果:1) 检出高被引文献133篇,纳入统计133篇,累计被引2880次(占总被引58.59%),篇均被引21.65次;2) 文献数自2015年开始上升,至峰值35篇后又迅速下降为2019年的7篇;3) 133篇高被引文献来自76种期刊,其中《中国肺癌杂志》《中国肺癌杂志》《中华肿瘤防治杂志》分别居文献数、总被引频次、篇均被引频次的第一位;4) 文献涉及作者332人、署名364人次,累计合作126篇,总合作率94.74%,作者周彩存、蒋涛、任秀宝、王慧娟、张力的署名数依次居第5名;5) 作者机构涉及100个,其中,医院36个(36%)、院校46个(46%)、科研院所15个(15%)、企业公司3个(3%)。最高产发文机构为天津医科大学,共6篇;6) 共涉及关键词244个、563次,篇均关键词1.83个;7) 133篇非小细胞肺癌治疗进展高被引文献中,获基金支持的文献共53篇,占39.85%;累计73项次,篇均1.38项次。结论:CNKI数据库非小细胞肺癌治疗进展高被引文献展现出以医院为核心发文机构、以《中国肺癌杂志》《中华肿瘤防治杂志》为权威期刊、以非小细胞肺癌治疗进展主要研究对象、以省部级以上项目为主要资助基金的特征,形成了以周彩存、蒋涛、任秀宝、王慧娟、张力等为代表的核心团队,但关键词使用不够规范,资助资金偏少,近2年文献数量较前有所减少。

Objective: To analyze the bibliometric characteristics of highly cited literatures on the treatment progress of non-small cell lung cancer in China. Methods: The literatures on the treatment progress of non-small cell lung cancer in China academic journal full text database (CNKI) from 2014 to 2020 were searched, and the highly cited literatures were determined according to price's law. The citation frequency, publication year, journal name, literature author, author organization, keyword and fund category were statistically analyzed by Excel 2016. Results: 1) 133 highly cited literatures were detected and 133 were included in the statistics, with a total of 2880 citations (58.59%) and 21.65 citations;2) The number of literatures began to rise in 2015, peaked at 35, and then rapidly decreased to 7 in 2019;3) 133 highly cited literatures come from 76 journals, among which Chinese Journal of Lung Cancer, Chinese Journal of Lung Cancer and Chinese Journal of Cancer Prevention and Treatment rank first in the number of articles, total cited frequency and articles cited frequency respectively;4) The literature involved 332 authors and 364 signatures, with a total cooperation rate of 94.74%. The authors Zhou Caicun, Jiang Tao, Ren Xiubao, Wang Huijuan and Zhang Li ranked fifth in the number of signatures;5) The author has 100 institutions, including 36 hospitals (36%), 46 universities (46%), 15 scientific research institutes (15%) and 3 enterprises (3%). Tianjin Medical University is the most prolific publishing institution, with a total of 6 articles;6) 244 keywords and 563 times were involved, with an average of 1.83 keywords;7) Among the 133 highly cited articles on the treatment progress of non-small cell lung cancer, 53 articles were supported by the foundation, accounting for 39.85%;there are 73 items in total, with an average of 1.38 items. Conclusion: The CNKI database of highly cited literatures on treatment progress of NSCLC shows the characteristics of taking the hospital as the core issuing institution, taking China Journal of lung Cancer and China Journal of Cancer Prevention and Treatment as authoritative journals, taking the treatment progress of non-small cell lung cancer as the main research object, and taking projects above the provincial and ministerial level as the main funding funds. A core team represented by Zhou Caicun, Jiang Tao, Ren Xiubao, Wang Huijuan and Zhang Li has been formed, but the use of keywords is not standardized, the funding is relatively small, and the number of documents in recent two years has decreased compared with the previous years.